Tag Archives: NASDAQ:SPNE

A Director at SeaSpine Holdings (NASDAQ: SPNE) is Selling Shares

Today, a Director at SeaSpine Holdings (NASDAQ: SPNE), John Henneman, sold shares of SPNE for $146.8K. Following John Henneman’s last SPNE Sell transaction on June 13, 2018, the stock climbed by 0.8%. In addition to John Henneman, one other SPNE

H.C. Wainwright Sticks to Their Buy Rating for SeaSpine Holdings

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on SeaSpine Holdings (NASDAQ: SPNE), with a price target of $15. The company’s shares closed yesterday at $12.25. According to TipRanks.com, Ramakanth is a 4-star analyst

Cantor Fitzgerald Keeps a Buy Rating on SeaSpine Holdings

Cantor Fitzgerald analyst Craig Bijou reiterated a Buy rating on SeaSpine Holdings (NASDAQ: SPNE) yesterday and set a price target of $16. The company’s shares closed yesterday at $12.25. Bijou wrote: “: We reiterate our Overweight rating and $16 PT

SeaSpine Holdings Receives a Buy from H.C. Wainwright

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on SeaSpine Holdings (NASDAQ: SPNE), with a price target of $15. The company’s shares closed yesterday at $10.83. According to TipRanks.com, Ramakanth is a 3-star analyst

BTIG Maintains a Buy Rating on SeaSpine Holdings

BTIG analyst Ryan Zimmerman maintained a Buy rating on SeaSpine Holdings (NASDAQ: SPNE) on March 1 and set a price target of $17. The company’s shares closed yesterday at $9.91. Zimmerman observed: “From New Products Should Set up FY18 SeaSpine

Analysts Offer Insights on Healthcare Companies: SeaSpine Holdings (NASDAQ: SPNE) and TherapeuticsMD (NYSE MKT: TXMD)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SeaSpine Holdings (NASDAQ: SPNE) and TherapeuticsMD (NYSE MKT: TXMD) with bullish sentiments. SeaSpine Holdings (NASDAQ: SPNE) In a report issued on November